Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Thrombosis and Thrombolysis
Published in: Journal of Thrombosis and Thrombolysis 1/2000

01-01-2000

Soluble E-Selectin is Not a Marker of Unstable Coronary Plaque in Serum of Patients with Ischemic Heart Disease

Authors: Marcello Galvani, Donatella Ferrini, Filippo Ottani, Cristina Nanni, Alessandro Ramberti, Paolo Amboni, Laura Iamele, Arialdo Vernocchi, Francesca A. Nicolini

Published in: Journal of Thrombosis and Thrombolysis | Issue 1/2000

Login to get access
Metadata
Title
Soluble E-Selectin is Not a Marker of Unstable Coronary Plaque in Serum of Patients with Ischemic Heart Disease
Authors
Marcello Galvani
Donatella Ferrini
Filippo Ottani
Cristina Nanni
Alessandro Ramberti
Paolo Amboni
Laura Iamele
Arialdo Vernocchi
Francesca A. Nicolini
Publication date
01-01-2000
Publisher
Kluwer Academic Publishers
Published in
Journal of Thrombosis and Thrombolysis / Issue 1/2000
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1023/A:1018656530541

Other articles of this Issue 1/2000

Journal of Thrombosis and Thrombolysis 1/2000 Go to the issue

OriginalPaper

Update in Unfractionated Heparin, Low-Molecular-Weight Heparins, and Heparinoids in the Elderly (Age ≤ 65 years)

OriginalPaper

Pharmacokinetics and Pharmacodynamics

OriginalPaper

Reference Guide to Cardiogenic Shock Complicating Acute Myocardial Infarction

OriginalPaper

Role of Extracellular Ionized Calcium in the In Vitro Assessment of GPIIb/IIIa Receptor Antagonists

OriginalPaper

Effect of Short-Term Aspirin Use on C-Reactive Protein

OriginalPaper

References on a Wide Variety of Topics Pertaining to Coronary Artery Blood Flow and Patency
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits